Preoperative Chemoradiotherapy and Postoperative Chemotherapy with Capecitabine +/- Oxaliplatin in Locally Advanced Rectal Cancer: Interim Analysis for Disease-Free Survival of Petacc 6

H.J. Schmoll,K. Haustermans,T.J. Price,B. Nordlinger, R. Hofheinz,J. Daisne, J.F. Janssens,B. Brenner,P. Schmidt, H.H. Reinel,S. Hollerbach,K. Caca, F.W.B. Fauth,C.V. Hannig,J. Zalcberg,N.C. Tebbutt,M. Mauer,C.G.M. Messina,M.P. Lutz,E. Van Cutsem

Annals of oncology : official journal of the European Society for Medical Oncology（2014）

引用 1|浏览22

暂无评分

摘要

Aim: The PETACC-6 trial investigates the role of oxaliplatin in addition to preoperative chemoradiation (CRT) and adjuvant chemotherapy (CT) with capecitabine to improve disease-free survival (DFS) in locally advanced rectal cancer.

查看译文

关键词

advanced rectal cancer,locally advanced rectal cancer,rectal cancer,postoperative chemotherapy,preoperative chemoradiotherapy,disease-free

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要